Compared with the TP53 wild-type group of PCa samples, the levels of VIRMA and IGFBP3 were higher and the level of IGFBP2 was lower in the TP53 mutation group (P < 0.001) (Fig. 2D and Table 5). The gene discussed is IGFBP3; the disease is posterior cortical atrophy.